Companies/HeartBeam, Inc.

Company profile

HeartBeam, Inc.

NASDAQ: BEAT · Healthcare · Medical - Specialties

PublicHQ Santa Clara, CA · Santa ClaraCIK 0001779372Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 18DQ —GM —SS 34

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$21.0M

Employees

as of 2026-08-21

Market cap

$26.5M

as of 2026-08-21

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$21.0M-$21.0M2025

Operating income-$21.1M-$21.1M2025

Total assets$5.8M$5.8M2025

Liabilities$3.2M$3.2M2025

Equity$2.6M$2.6M2025

Revenue by segment

Filed disclosures · FY2019

By product

MonitoringCommercial50%

MonitoringMedicare35%

ClinicalTrialSupportandRelatedServices12%

TechnologyDevicesConsumablesandRelatedServices3%

By geography

Not disclosed.

The read

What is HeartBeam, Inc.’s financial profile?

HeartBeam, Inc. earned -$21.0M in FY2025 net income.

Peers · Healthcare

LeonaBio, Inc.——Sernova Corp.——Sangamo Therapeutics, Inc.——Tevogen Bio Holdings Inc.——Actuate Therapeutics Inc——NurExone Biologic Inc.——

Neighbors

Santa Clara →

NVIDIA Corporation$215.9B90A Apple Inc.$416.2B84B+Alphabet Inc.$402.8B81B+Broadcom Inc.$63.9B76B+Advanced Micro Devices, Inc.$34.6B78B+Cisco Systems, Inc.$56.7B85A

Key facts

CEORobert Eno

SectorHealthcare

IndustryMedical - Specialties

HeadquartersSanta Clara, CA

ExchangeNASDAQ: BEAT

Employees16

IPO date2021-11-16

Latest filings

8-K2026-07-02 8-K2026-06-24 8-K2026-06-22 DEF 14A2026-06-18 10-Q2026-05-13 8-K2026-04-16 10-K2026-03-12 8-K2025-11-21

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.